Triamcinolone

Generic Name: Triamcinolone

Brand Names: Allernaze, Aristocort, Aristocort R, Juulissa Pharmapak, Kenalog, Kourzeq, Marcaine, Nasacort, Oracort, Oralone, Pediaderm Ta, Triaderm, Trianex, Triderm, Triesence, Triloan Suik, Tritocin, Viaderm Kc, Xipere, Zilretta

Drug Type: Small Molecule

Chemical Formula: C_₂₁H_₂₇FO_₆

CAS Number: 124-94-7

Unique Ingredient Identifier: 1ZK20VI6TY

Background: Triamcinolone is a corticosteroid used to treat various inflammatory conditions in the body from allergic rhinitis to acute exacerbations of multiple sclerosis. Triamcinolone can be used as a one time adjunct treatment of osteoarthritic knee pain, or first line as a topical treatment of corticosteroid responsive dermatoses. Triamcinolone is more commonly see...

Indication: 肾上腺皮质激素类药。主要用于过敏性与自身免疫性炎症性疾病。由于本品潴钠作用较弱，故一般不用作肾上腺皮质功能减退的替代治疗。

Associated Conditions: Acne, Acne Vulgaris, Acute Gouty Arthritis, Allergic Contact Dermatitis, Allergic Rhinitis (AR), Allergic Skin Reaction, Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aphthous Stomatitis, Asthma, Atopic Dermatitis, Autoimmune Hemolytic Anemia, Berylliosis, Bullous dermatitis herpetiformis, Chronic Eczema, Chronic Inflammatory Skin Diseases, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Contact Dermatitis, Crohn's Disease (CD), Dental Cavity, Dermatitis, Dermatomyositis (DM), Diaper Rash, Discoid Lupus Erythematosus (DLE), Edema of the cerebrum, Epicondylitis, Erythroderma, Fungal Infections, Fungal infectious disorders of the Beard, Fungal skin infection, Gingivitis, Haemorrhoids, Hemangiomas, Hypercalcemia, Inflammation of Mouth, Intertrigo, Itching of the Anus, Itching of the External Genitalia, Itching of the Foot, Itching of the genitals, Itching of the hand, Juvenile Idiopathic Arthritis (JIA), Keloids Scars, Leukemias, Lichen Planus (LP), Lichen simplex chronicus, Lymphoma, Macular Edema, Mycosis Fungoides (MF), Mycotic Eczema, Necrobiosis lipoidica diabeticorum, Neurodermatitis, Nummular Dermatitis, Ocular Inflammation, Ophthalmia, Sympathetic, Oral Erosive Lichen Planus, Otitis Externa, Pemphigus, Pericarditis, Polymyositis, Postherpetic Neuralgia, Primary adrenocortical insufficiency, Proteinuria, Psoriasis Vulgaris (Plaque Psoriasis), Psoriatic Arthritis, Psoriatic plaque, Pure Red Cell Aplasia, Purulent Wounds, Pyoderma caused by susceptible bacteria, Regional Enteritis, Rheumatoid Arthritis, Ringworm Folliculitis, Seborrheic Dermatitis, Seborrheic Dermatitis, Eczematous, Secondary Impetiginization, Secondary adrenocortical insufficiency, Secondary thrombocytopenia, Serum Sickness, Skin chapped, Stomatitis, Denture, Synovitis, Systemic Lupus Erythematosus, Temporal Arteritis, Tinea Corporis, Transfusion Reactions, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Urticaria, Uveitis, Wound Infections, Acute Bursitis, Acute Multiple sclerosis, Acute Rheumatic heart disease, unspecified, Acute Tenosynovitis, Corticosteroid-responsive dermatoses, Cutaneous candidiasis, Cystic tumour of the ganglia, Exfoliative erythroderma, Granuloma annulare lesions, Idiopathic eosinophilic pneumonias, Non-suppurative Thyroiditis, Oral infections, Oral lesions, Severe Erythema multiforme, Subacute Dermatitis, Eczematous, Symptomatic Sarcoidosis, Ulceration of the mouth, Ulcerative stomatitis

Associated Therapies: -

Clinical Trials

Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury

Phase 2

Terminated

Conditions: Tibial Meniscus Injuries
Tibial Meniscus Tears
Tibial Meniscus, Torn
Anterior Cruciate Ligament Tear

Interventions: Other: Placebo
Drug: Zilretta

First Posted Date: 2020-04-02

Last Posted Date: 2023-07-27

Lead Sponsor: Austin V Stone

Target Recruit Count: 1

Registration Number: NCT04331002

Locations: 🇺🇸
UK Healthcare at Turfland, Lexington, Kentucky, United States

Treatment Results for Patients with Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study

Phase 4

Recruiting

Conditions: Central Centrifugal Cicatricial Alopecia (CCCA)

Interventions: Drug: Topical steroid class I-II
Drug: Doxycyline
Drug: Triamcinolone Acetonide
Drug: Minoxidil

First Posted Date: 2019-12-23

Last Posted Date: 2024-10-02

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 250

Registration Number: NCT04207931

Locations: 🇺🇸
Wake Forest Baptist Health Department of Dermatology, Winston-Salem, North Carolina, United States

Effect of Addition of Steroids on Duration of Analgesia

Early Phase 1

Active, not recruiting

Conditions: Uterine Fibroids
Adenomyosis

Interventions: Drug: Bupivacaine
Drug: Triamcinolone
Other: Iohexol contrast

First Posted Date: 2019-10-15

Last Posted Date: 2024-05-13

Lead Sponsor: University of California, Los Angeles

Target Recruit Count: 28

Registration Number: NCT04126824

Locations: 🇺🇸
University of California, Los Angeles, Westwood, California, United States
🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States